Voluntis
Healthcare software company .
Launch date
Market cap
-
Enterprise valuation
€106m (Public information from May 2018)
Share price
€8.7 VTX.PA
Company register number 439685850
Suresnes Île-de-France (HQ)
- hard tech
- biotechnology
- sustainable development goals
- risk management
- testing
- entertainment
- arts & culture
- immersive technologies
- oncology
- predictive analytics
- observatoire deeptech
- neurology
- diabetes
- crm
- tech for patients
- personal health
- biotech, medtech and e-health
- digital care
- tech for biotech & pharma
- digital therapeutics
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | 7.0m | 4.0m | 3.0m | 4.0m | 8.0m | 10.0m |
| % growth | - | (43 %) | (25 %) | 33 % | 100 % | 25 % |
| EBITDA | (9.0m) | (15.0m) | (14.0m) | (7.0m) | (5.0m) | (2.0m) |
| % EBITDA margin | (129 %) | (375 %) | (467 %) | (175 %) | (63 %) | (20 %) |
| Profit | (10.0m) | (15.0m) | (15.0m) | (12.0m) | (8.0m) | (5.0m) |
| % profit margin | (143 %) | (375 %) | (500 %) | (300 %) | (100 %) | (50 %) |
| EV / revenue | - | 5.3x | 7.0x | 9.0x | - | - |
| EV / EBITDA | - | -1.4x | -1.5x | -5.1x | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
€2.0m | Early VC | ||
$29.0m | Series D | ||
€30.1m Valuation: €106m 15.1x EV/LTM Revenues -11.8x EV/LTM EBITDA | IPO | ||
| N/A | N/A | Post IPO Equity | |
N/A | Acquisition | ||
| Total Funding | €28.4m | ||
Related Content
Recent News about Voluntis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.